Chemical Restraint Sample Clauses
The Chemical Restraint clause defines the conditions under which chemical substances may be used to restrict a person's movement or behavior, typically in healthcare or institutional settings. It outlines the specific circumstances, such as emergencies or when less restrictive interventions have failed, and may require authorization from a qualified professional. This clause ensures that chemical restraints are used safely, ethically, and only when absolutely necessary, thereby protecting individuals' rights and minimizing the risk of misuse or harm.
Chemical Restraint. Chemical restraint means any drug that is prescribed or administered to sedate an individual, or temporarily restrict an individual’s freedom of movement, for the purpose of managing the individual’s behavior.
Chemical Restraint. Any drug that is administered to manage a member’s behavior in a way that reduces the safety risk to the member or others and has the temporary effect of restricting the resident’s freedom of movement. Chemical restraints do not include drugs that are a standard treatment for the member’s medical or psychiatric condition. A claim for payment of services that has no defect, impropriety or special circumstance, including incomplete documentation that delays timely payment.
Chemical Restraint i. Mechanical restraint (that does not include devices used by trained school personnel, or by a student, for the specific and approved therapeutic or safety purposes for which such devices were designed and, if applicable, prescribed);
j. Using other students or untrained staff to assist with the hold or restraint;
k. Securing a student to another student or fixed object;
l. Aversive behavioral interventions; or
m. Seclusion in a locked room or area.
Chemical Restraint. The Facility shall not use chemical restraint. 1. A chemical restraint is the administration of a drug or medication when it is used as a restriction to manage the resident's behavior or restrict the resident's freedom of movement and is not a standard treatment or dosage for the resident's condition. 2. Orders or prescriptions for the administration of medications to be used as a restriction to manage the resident's behavior or restrict the resident's freedom of movement shall not be written as a standing order or on an as‐needed basis (PRN). Section V.D. Evaluation Criteria Person Responsible Documentation for Verification Next Steps Status
14. There were zero instances of drug / medication use to manage resident behavior OR to restrain freedom of movement. ▇▇▇▇ ▇▇▇▇▇ During the interval of this status report there were no reported instances of drug/ medication use to manage resident behavior or to restrain freedom of movement 11‐17‐12 update During the interval of this status report there were no reported instances of drug/ medication use to manage resident behavior or to restrain freedom of movement 1‐17‐13 update See EC #6 In examining the use of PRN medication, both the Internal Reviewer and a psychiatric practitioner designated by the SOS Chief Medical Officer will participate in the review. Department anticipates requesting release from judicial oversight on 3‐5‐13. T 1‐17‐13 update During the interval of this status report there were no reported instances of drug/ medication use to manage resident behavior or to restrain freedom of movement. A PRN protocol was developed, staff trained and protocol implemented on 1‐1‐13. (Exhibit 113)
15. There were zero instances of PRN orders (standing orders) of drug/ medication used to manage behavior or restrict freedom of movement. ▇▇▇▇ ▇▇▇▇▇ During the interval of this status report there were no reported instances of PRN orders (standing orders) of drug/medication used to manage behavior or restrict freedom of movement 11‐17‐12
Chemical Restraint. Any drug that is administered to manage a member’s behavior in a way that reduces the safety risk to the member or others and has the temporary effect of restricting the individual’s freedom of movement. Chemical Restraints do not include drugs that are a standard treatment for the member’s medical or psychiatric condition. In accordance with 42 CFR § 447.45 (b) a claim that can be processed without obtaining additional information from the provider of the service or from a third party. It includes a claim with errors originating in a PASSE’s claims system. It does not include a claim from a provider who is under investigation for fraud or abuse, or a claim under review for medical necessity.
Chemical Restraint. If a Provider uses a restraint, the Provider must: